首页> 美国卫生研究院文献>Journal of Diabetes Investigation >Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes

【2h】

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes

机译：从每日两次艾塞那肽转为2型糖尿病患者后每周一次艾塞那肽的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To evaluate the efficacy and safety of once‐weekly ( ) extended‐release exenatide after switching from twice‐daily ( ) exenatide in patients with type 2 diabetes.

机译：为了评估在2型糖尿病患者中从每天两次（）艾塞那肽转为每周一次（）延长释放艾塞那肽的疗效和安全性。

著录项

期刊名称 Journal of Diabetes Investigation
作者
Yuusuke Watanabe; Yoshifumi Saisho; Jun Inaishi; Kinsei Kou; Akira Yamauchi; Yasuhiko Kanazawa; Yoshiaki Okubo; Mikiya Tokui; Takatoshi Imai; Rie Murakami; Tami Tsuchiya; Hironobu Sasaki; Tatsuhiro Masaoka; Junichiro Irie; Shu Meguro; Hiroshi Itoh; for the Twin‐exenatide Study Group;
展开▼
作者单位

展开▼
年(卷),期 2020(11),2
年度 2020
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Glucagon‐like peptide‐1 receptor agonist; Treatment satisfaction; Type 2 diabetes;

机译：胰高血糖素样肽-1受体激动剂;治疗满意度;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type?2 diabetes [J] . Yuusuke Watanabe, Yoshifumi Saisho, Jun Inaishi, Journal of diabetes investigation. . 2020,第2期

机译：在患有2型糖尿病患者的两次exenatide后切换后，一次每周杂交的疗效和安全性
2. Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial [J] . Jabbour Serge A., Frias Juan P., Hardy Elise, Diabetes care . 2018,第10期

机译：Exenatide每周一次的安全性和疗效加上Dapagliflozin每日一度，并且单独服用exenatide或Dapagliflozin，患有2型糖尿病的患者与二甲双胍单疗法不充分控制：52周的持续时间-8随机对照试验
3. Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus [J] . JiL., OnishiY., AhnC.W., Journal of diabetes investigation. . 2013,第1期

机译：在亚洲2型糖尿病患者中，艾塞那肽每周一次与艾塞那肽每天两次的疗效和安全性
4. Reinforcement Learning-Based Adaptive Insulin Advisor for Individuals with Type 1 Diabetes Patients under Multiple Daily Injections Therapy^* [C] . Qingnan Sun, Marko V. Jankovic, Stavroula G. Mougiakakou Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2019

机译：基于强化学习的1型糖尿病患者每日多次注射疗法的自适应胰岛素顾问^*
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial [O] . Serge A. Jabbour, Juan P. Frías, Elise Hardy, 2018

机译：二甲双胍单药治疗不能完全控制的2型糖尿病患者艾塞那肽每周一次加艾达那列或每日一次与艾塞那肽或达格列净相比的安全性和有效性：DURATION-8随机对照试验52周的结果
7. Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes [O] . Yuusuke Watanabe, Yoshifumi Saisho, Jun Inaishi, 2019

机译：在2型糖尿病患者中从每日两次exenatide切换后一次每周杂交的疗效和安全性

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes

摘要

著录项

相似文献

相关主题

期刊订阅